Literature DB >> 2441079

3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus.

J C Olsen, P Furman, J A Fyfe, R Swanstrom.   

Abstract

We tested the ability of the thymidine analog 3'-azido-3'-deoxythymidine (BWA509U) to inhibit the replication of the retrovirus avian leukosis virus. Inhibition was measured with two different assays: inhibition of a single round of virus replication and inhibition of virus spread through a cell culture. With both assays, we detected inhibition of virus growth, although inhibition of a single round of virus replication required a 40-fold higher drug concentration than did inhibition of virus spread. We also detected variations in the concentrations of drug needed to inhibit virus replication in different cell types. Higher concentrations of drug were needed to inhibit virus replication in chicken embryo fibroblasts than in the continuous quail cell line QT6. Viral DNA synthesis in infected cells was shown to be inhibited in the presence of the drug. The triphosphate form of the analog acted as a competitive inhibitor of purified viral reverse transcriptase, with a Ki of 0.09 +/- 0.003 microM, and was incorporated as a chain terminator during reverse transcription of the natural viral RNA substrate in vitro.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2441079      PMCID: PMC255789     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  22 in total

1.  Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells.

Authors:  H E Varmus; S Heasley; H J Kung; H Oppermann; V C Smith; J M Bishop; P R Shank
Journal:  J Mol Biol       Date:  1978-03-25       Impact factor: 5.469

2.  RNA-dependent DNA polymerase in virions of RNA tumour viruses.

Authors:  D Baltimore
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  RNA-dependent DNA polymerase of avian sarcoma virus B77. II. Comparison of the catalytic properties of the alpha, beta2, and alphabeta enzyme forms.

Authors:  A Hizi; J P Leis; W K Joklik
Journal:  J Biol Chem       Date:  1977-04-10       Impact factor: 5.157

6.  Statistical methods to distinguish competitive, noncompetitive, and uncompetitive enzyme inhibitors.

Authors:  T Spector; G Hajian
Journal:  Anal Biochem       Date:  1981-08       Impact factor: 3.365

7.  On the fidelity of DNA replication. Lack of exodeoxyribonuclease activity and error-correcting function in avian myeloblastosis virus DNA polymerase.

Authors:  N Battula; L A Loeb
Journal:  J Biol Chem       Date:  1976-02-25       Impact factor: 5.157

8.  Molecular cloning and characterization of avian sarcoma virus circular DNA molecules.

Authors:  W J DeLorbe; P A Luciw; H M Goodman; H E Varmus; J M Bishop
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

9.  Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail.

Authors:  C Moscovici; M G Moscovici; H Jimenez; M M Lai; M J Hayman; P K Vogt
Journal:  Cell       Date:  1977-05       Impact factor: 41.582

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  6 in total

Review 1.  Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

2.  Rearrangements in unintegrated retroviral DNA are complex and are the result of multiple genetic determinants.

Authors:  J C Olsen; C Bova-Hill; D P Grandgenett; T P Quinn; J P Manfredi; R Swanstrom
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

3.  Resumption of virus production after human immunodeficiency virus infection of T lymphocytes in the presence of azidothymidine.

Authors:  M S Smith; E L Brian; J S Pagano
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 4.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

5.  (-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro.

Authors:  J A Coates; N Cammack; H J Jenkinson; A J Jowett; M I Jowett; B A Pearson; C R Penn; P L Rouse; K C Viner; J M Cameron
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

6.  Preferential incorporation of nucleoside analogs after template switching during human immunodeficiency virus reverse transcription.

Authors:  E J Arts; M A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.